Evaluation of the Antiproliferative Activity of Some Nanoparticulate Essential Oils Formulated in Microemulsion on Selected Human Carcinoma Cell Lines.
Journal: 2018/April - Current Clinical Pharmacology
ISSN: 2212-3938
Abstract:
BACKGROUND
Essential oils (EOs) are natural volatile plant extracts that have different biological activities including antiproliferative potentials.
OBJECTIVE
The current study aims at evaluating the antiproliferative activities against some cancer cell lines of six EOs in their neat oily state and in water-based microemulsions where the EOs exist as nanoparticles. The EOs included marjoram (Origanum majorana), turmeric (Curcuma longa), sweet basil (Ocimum basillicum), clove buds (Syzygium aromaticum), geranium (plargonium graviolenis), and black cumin (Nigella sativa).
METHODS
GC-MS chromatographic analysis was used to reveal the chemical composition of EOs. Self-microemulsification method and oil titration method were used for the fabrication of the different microemulsions. MTT assay and IC50 determinations were used for evaluating the extent of the antiproliferative activity.
RESULTS
Results indicated that geranium EO was the most active against the evaluated cancer cell lines followed by basil EO and marjoram EO. On the other hand, turmeric followed by black cumin EOs showed the least antiproliferative activity relative to the other EOs. Clove EO showed selective activity depending on the type of cancer cell lines. Formulation of these EOs in microemulsions led to the development of water-borne nanoparticles having an average particle size from 10.7nm to 18.0 nm depending on the type of EO. Re-evaluation of the antiproliferative activity of these EOs after microemulsification showed differential behavior ranging from activity enhancement to retardation relative to the original activity of each corresponding neat EO in its oily state. Potential factors that could justify the obtained results are discussed.
CONCLUSIONS
Some EOs and their microemulsions may potentially be used as natural adjuvants to classical anti-cancer drugs.
Relations:
Drugs
(5)
Similar articles
Articles by the same authors
Discussion board
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.